Barrett's Oesophagus and Carcinoma

References

• Barrett N R. Chronic peptic ulcer of the oesophagus and oesophagitis. Br J Surg 1950; 38: 175–82
   PubMed Web of Science ®Google Scholar
• Allison P R, Johnstone A S. The esophagus lined with gastric mucous membrane. Thorax 1953; 8: 87–101
   PubMed Web of Science ®Google Scholar
• Paull A, Trier J S, Dalton M D, Camp R C, Loeb P, Goyal R K. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476–80
   PubMed Web of Science ®Google Scholar
• Thompson J J, Zinsser K R, Enterline H T. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 1983; 14: 42–61
   PubMed Web of Science ®Google Scholar
• Woolf G M, Riddell R H, Irvine E J, Hunt R H. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. Gastrointest Endosc 1989; 35: 541–4
   PubMedGoogle Scholar
• McClave S A, Boyce H W, Gottfried M R. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987; 33: 413–6
   PubMed Web of Science ®Google Scholar
• Van Asche C, Rahm A E, Goldner F, Crumbaker D. Columnar mucosa in the proximal esophagus. Gastrointest Endosc 1988; 34: 324–6
   PubMedGoogle Scholar
• Feurle G E, Helmstaedter V, Buehring A, Bettendorf U, Eck-Ardt V F. Distinct immunochemical findings in columnar epithelium of oesophageal inlet patch and of Barrett's esophagus. Dig Dis Sci 1990; 35: 86–92
   PubMedGoogle Scholar
• Iascone C, DeMeester T R, Little A G, Skinner D B. Barrett's esophagus: functional assessment, proposed pathogenesis and surgical therapy. Arch Surg 1983; 118: 543–9
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat G NJ. Columnar-lined (Barrett's) esophagus. Thesis, University of Amsterdam. 1989; 139–48
   Google Scholar
• Gillen P, Keeling P, Byrne P J, Hennessey T PJ. Barrett's oesophagus: pH profile. Br J Surg 1987; 74: 774–6
   PubMedGoogle Scholar
• Mann N S, Tsai M F, Nair P K. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterology 1989; 84: 1494–6
   PubMed Web of Science ®Google Scholar
• Parilla P, Ortiz A, Martinez de Haro L F, Aguayo J L, Ramirez P. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus. Gut 1990; 31: 964–7
   PubMedGoogle Scholar
• Stein H J, Barlow A P, DeMeester T R, Hinder R A. Complications of gastroesophageal reflux disease: role of the lower oesophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992; 216: 35–43
   PubMed Web of Science ®Google Scholar
• Robertson D, Aldersley M, Shepherd H, Smith C L. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 1484–8
   PubMed Web of Science ®Google Scholar
• Mulholland M W, Reid B J, Levine D S, Rubin C E. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci 1989; 34: 1329–35
   PubMedGoogle Scholar
• Collen M J, Johnson D A. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sci 1992; 37: 570–6
   PubMedGoogle Scholar
• Hirschowitz B I, Barton J. Gastric acid and pepsin secretion in patients with Barrett's esophagus (BES). Gastroenterology 1990; 98: A60
   Google Scholar
• Meyer W, Vollmar F, Bar W. Barrett-esophagus following total gastrectomy. Endoscopy 1979; 2: 121–6
   Google Scholar
• Gillen P, Keeling P, Byrne P J, Heaiy M, O'Moore R R, Hen-Nessy T PJ. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg 1988; 75: 540–3
   PubMed Web of Science ®Google Scholar
• Gotley D C, Morgan A P, Ball D, Owen R W, Cooper M J. Composition of gastro-oesophageal refluxate. Gut 1991; 2: 1093–9
   Google Scholar
• Attwood S EA, DeMeester T R, Bremner C G, Barlow A P, Hinder R A. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery 1989; 106: 764–70
   PubMed Web of Science ®Google Scholar
• Attwood S EA, Ball C S, Barlow A P, Jenkinson L, Norris T L, Watson A. Role of intragastric and intraoesophageal alk-alinisation in the genesis of complications in Barrett's columnar lined lower oesophagus. Gut 1993; 34: 11–5
   PubMed Web of Science ®Google Scholar
• Singh S, Bradley L A, Richter J E. Determinants of oesophageal ‘alkaline’ pH environment in controls and patients with gastro-oesophageal reflux disease. Gut 1993; 34: 309–16
   PubMed Web of Science ®Google Scholar
• Spechler S J, Schimmel E M, Dalton J W, Doos W, Trier J S. Barrett's epithelium complicating lye ingestion with sparing of the distal esophagus. Gastroenterology 1981; 81: 580–3
   PubMedGoogle Scholar
• Dahms B B, Greco M A, Strandjord S E, Rothstein F C. Barrett's esophagus in three children after antileukemia chemotherapy. Cancer 1987; 60: 2896–900
   PubMed Web of Science ®Google Scholar
• Sartori S, Nielsen I, Indelli M, Trevisani L, Pazzi P, Grandi E. Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF): an iatrogenic injury. Ann Intern Med 1991; 114: 210–1
   PubMedGoogle Scholar
• Herrera J L, Uzel C, Martino R, Cooke C, DiPalma J A. Barrett's esophagus: lack of association with adjuvant chemotherapy for localized breast carcinoma. Gastrointest Endosc 1992; 38: 551–3
   PubMedGoogle Scholar
• Peters F TM, Sleijfer D Th, van Imhoff G W, Kleibeuker J H. Is chemotherapy associated with development of Barrett's esophagus. Dig Dis Sci 1993; 38: 923–6
   PubMedGoogle Scholar
• Crabb D W, Berk M A, Hall T R, Conneally P M, Biegel A A, Lehman G A. Familial gastroesophageal reflux and development of Barrett's esophagus. Ann Intern Med 1985; 103: 52–4
   PubMedGoogle Scholar
• Jochem V J, Fuerst P A, Fromkes J J. Familial Barrett's esophagus associated with adenocarcinoma. Gastroenterology 1992; 102: 1400–2
   PubMed Web of Science ®Google Scholar
• GOSPE. Barrett's esophagus: epidemiological and clinical results of a multicentric survey. Int J Cancer 1991; 48: 364–8
   PubMedGoogle Scholar
• Winters C, Spurling T J, Chobanian S J, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118–24
   PubMed Web of Science ®Google Scholar
• Spechler S J, Sperber H, Doos W G, Schimmel E M. The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures. Dig Dis Sci 1983; 28: 769–74
   PubMed Web of Science ®Google Scholar
• Cameron A J, Lomboy C T. Barrett's esophagus: age, prevalence and extent of columnar epithelium. Gastroenterology 1992; 103: 1241–5
   PubMed Web of Science ®Google Scholar
• Cameron A J, Zinsmeister A R, Ballard D J, Carney J A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918–22
   PubMed Web of Science ®Google Scholar
• Menke-Pluymers M BE, Schoute N W, Mulder A H, Hop W CJ, Van Blankenstein M, Tilanus H W. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992; 33: 1454–8
   PubMed Web of Science ®Google Scholar
• Hesketh P J, Clapp R W, Doos W G, Spechler S J. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989; 64: 526–30
   PubMed Web of Science ®Google Scholar
• Pera M, Cameron A J, Trastek V F, Carpenter H A, Zinsmeister A R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510–3
   PubMed Web of Science ®Google Scholar
• Hellemans N, Julius J. Hiatus hernia associated with malignancy in the region of the cardia. Am J Dig Dis 1965; 10: 467–80
   Google Scholar
• Naef A P, Savary M, Ozzello L. Columnar-lined lower oesophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975; 70: 826–34
   PubMed Web of Science ®Google Scholar
• Cameron A J, Ott B J, Payne W S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857–9
   PubMed Web of Science ®Google Scholar
• Collins B J, Abbott M, Thomas R JS, Morstyn G, St John. DJB. Clinical profile in Barrett's esophagus: who should be screened for cancer? Hepato-Gastroenterol 1991; 38: 341–4
   Google Scholar
• Streitz J M, Ellis F H, Gibb S P, Balogh K, Watkins E. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991; 213: 122–5
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat G NJ, Houthoff H J, Van den Tweel J G. Barrett's oesophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249–56
   PubMed Web of Science ®Google Scholar
• Spechler S J, Robbins A H, Bloomfield Rubins H, et al. Adenocarcinoma and Barrett's oesophagus. An overrated risk? Gastroenterology 1984; 87: 927–33
   PubMed Web of Science ®Google Scholar
• Van der Veen A H, Dees J B, Iankensteijn J D, Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14–8
   PubMedGoogle Scholar
• Robertson C S, Mayberry J F, Nicholson D A, James P D, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75: 760–3
   PubMed Web of Science ®Google Scholar
• Ovaska J, Miettinen M, Kivilaakso E. Adenocarcinoma arising in Barrett's esophagus. Dig Dis Sci 1989; 34: 1336–9
   PubMedGoogle Scholar
• Skinner D B. The incidence of cancer in Barrett's oesophagus varies according to series. Benign lesions of the oesophagus and cancer, R Giulu, R W McCalhoun. Springer-Verlag, Berlin 1989; 764–5
   Google Scholar
• Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991; 32: 1441–6
   PubMed Web of Science ®Google Scholar
• Williamson W A, Ellis F H, Gibb S P, et al. Barrett's esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151: 2212–6
   PubMedGoogle Scholar
• Reid B J, Blount P L, Rubin C E, Levine D S, Haggitt R C, Rab-Inovitch P S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212–9
   PubMed Web of Science ®Google Scholar
• Reid B J, Haggitt R C, Rubin C E, Rabinovitch P S. Barrett's esophagus; correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987; 93: 1–11
   PubMed Web of Science ®Google Scholar
• Robaszkiewicz M, Hardy E, Volant A, et al. Analyse du contenu cellulaire en ADN par cytométrie en flux dans les endo-brachyoesophages; étude de 66 cas. Gastroenterol Clin Biol 1991; 15: 703–10
   PubMedGoogle Scholar
• James P D, Atkinson M. Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus. Gut 1989; 30: 899–905
   PubMedGoogle Scholar
• James P D, Wencyk P M, Iftikhar S A. DNA image cytometry as a predictor of malignant potential in Barrett's oesophagus. Eur J Gastroenterol Hepatol 1992; 4: 381–5
   Google Scholar
• Rabinovitch P S, Reid B J, Haggitt R C, Norwood T H, Rubin C E. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 1988; 60: 65–71
   Web of Science ®Google Scholar
• Fennerty M B, Sampliner R E, Way D, Riddell R, Steinbronn K, Garewal H S. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989; 97: 815–20
   PubMed Web of Science ®Google Scholar
• Ramel S, Reid B J, Sanchez C A, et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 1992; 102: 1220–8
   PubMed Web of Science ®Google Scholar
• Jankowski J, Coghill G, Hopwood D, Wormsley K G. Oncogenes and oncosuppressor gene in adenocarcinoma of the oesophagus. Gut 1992; 33: 1033–8
   PubMed Web of Science ®Google Scholar
• Preston-Martin S, Pike M C, Ross R K, Jones P A, Henderson B E. Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415–21
   PubMed Web of Science ®Google Scholar
• Morstyn G, Pyke K, Gardner J, Ashcroft R, Fazio D A, Bhathal P. Immunohistochemical identification of proliferating cells in organ culture using bromodeoxyuridine and a monoclonal antibody. J Histochem Cytochem 1986; 34: 697–701
   PubMedGoogle Scholar
• Harms G, van Goor H, Koudstaal J, De Ley L, Hardonk M J. Immunohistochemical demonstration of DNA-incorporated 5-bromodeoxyuridine in frozen and plastic embedded sections. Histochemistry 1986; 85: 139–43
   PubMedGoogle Scholar
• Herbst J J, Berenson M M, McCloskey D W, Wiser W C. Cell proliferation in oesophageal columnar epithelium (Barrett's esophagus). Gastroenterology 1978; 75: 683–7
   PubMedGoogle Scholar
• Pellish L J, Hermos J A, Eastwood G L. Cell proliferation in three types of Barrett's epithelium. Gut 1980; 21: 26–31
   PubMed Web of Science ®Google Scholar
• Peters F TM, Ganesh S, Hardonk M J, Elema J F, Lamers C BHW, Kleibeuker J H. Increased cell proliferation in actively inflamed Barrett's epithelium: marker for increased cancer risk. Gastroenterology 1993; 104: A441
   Google Scholar
• Jankowski J, McMenemin R, Hopwood D, Penston J, Wormsley K G. Abnormal expression of growth regulatory factors in Barrett's oesophagus. Clin Sci 1991; 81: 663–8
   PubMed Web of Science ®Google Scholar
• Iftikhar S Y, Steele R JC, Watson S, James P D, Dilks K, Hardcastle J D. Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus. Gut 1992; 33: 733–7
   PubMedGoogle Scholar
• Gray M R, Hall P A, Nash J, Ansari B, Lane D P, Kingsnorth A N. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992; 103: 1769–76
   PubMed Web of Science ®Google Scholar
• Jankowski J, McMenemin R, Yu C, Hopwood D, Wormsley K G. Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression. Gut 1992; 33: 587–91
   PubMed Web of Science ®Google Scholar
• Iftikhar S Y, James P D, Steele R JC, Hardcastle J D, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155–8
   PubMed Web of Science ®Google Scholar
• Brand D L, Ylvisaker J T, Gelfand M, Pope C E. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery. N Engl J Med 1980; 302: 844–8
   PubMed Web of Science ®Google Scholar
• Hassall E, Weinstein W M. Partial regression of childhood Barrett's esophagus after fundoplication. Am J Gastroenterology 1992; 87: 1506–12
   PubMedGoogle Scholar
• Attwood S EA, Barlow A P, Norris T L, Watson A. Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg 1992; 79: 1050–3
   PubMedGoogle Scholar
• Perniceni T, Leyma Tios J, Molas G, Fékéte F. L'endo-brachyoesophage régresse-t-il aprés diversion duodenale totale. Gastroenterol Clin Biol 1988; 12: 709–12
   PubMedGoogle Scholar
• Wesdorp I CE, Bartelsman J, Schipper M EI, Tytgat G N. Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus. Gut 1981; 22: 724–7
   PubMed Web of Science ®Google Scholar
• Sampliner R E, Garewal H S, Fennerty M B, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990; 35: 93–6
   PubMed Web of Science ®Google Scholar
• Ollyo J B, Gonvers J J, Froehlich F, et al. L'endobrachy-oeso-phage régresse-t-il aprés traitement efficace du reflux gastro-oesophagien. Schweiz med Wschr 1990; 120: 716–20
   PubMedGoogle Scholar
• Collen M J, Strong R M. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci 1992; 37: 897–903
   PubMed Web of Science ®Google Scholar
• Deviere J, Buset M, Dumonceau J-M, Richaert F, Cremer M. Regression of Barrett's epithelium with omeprazole. N Engl J Med 1989; 320: 1497–8
   PubMedGoogle Scholar
• Ottenjann R, Heidt H. Regression der Zylinderepithel-Met-aplasie bei Barrett-Oesophagus. Dtsch med Wschr 1990; 115: 916–7
   PubMedGoogle Scholar
• Gore S, Healey C J, Sutton R, Shepherd N A, Wilkinson S P. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Gastroenterology 1992; 102: A75
   Google Scholar
• Bologna S, Blumenkehl M, Schubert T T, Wong D. Barrett's esophagus response to long-term omeprazole therapy. Gas-trointest Endosc 1992; 38: A229
   Google Scholar
• Igbal T H, Neumann C S, Cooper B T. Omeprazole treatment of patients with Barrett's oesophagus. Gut 1993; 34: S19
   Google Scholar
• Sampliner R E, Mackel C, Jennings D, Greski-Rose P. Effect of 12 months of a proton pump inhibitor (lansoprazole) on Barrett's esophagus–a randomized trial. Gastroenterology 1992; 102: A517
   Google Scholar